Css LLC Decibel Therapeutics, Inc. Put Options Transaction History
Css LLC
- $1.01 Billion
- Q2 2024
About Decibel Therapeutics, Inc.
- Ticker DBTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,964,500
- Description
- Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...